-+ 0.00%
-+ 0.00%
-+ 0.00%

Evercore ISI Group Maintains Outperform on Caribou Biosciences, Raises Price Target to $13

Benzinga·03/09/2026 16:08:30
Listen to the news
Evercore ISI Group analyst Jonathan Miller maintains Caribou Biosciences (NASDAQ:CRBU) with a Outperform and raises the price target from $11 to $13.